| Basics |
Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company developing and commercializing pharmaceutical products. The company's products include Bloxiverz, Vazculep, Akovaz, Karbinal ER, AcipHex Sprinkle, Cefaclor and Flexichamber.
|
| IPO Date: |
July 1, 1996 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$1.53B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.23 | 3.05%
|
| Avg Daily Range (30 D): |
$0.25 | 1.95%
|
| Avg Daily Range (90 D): |
$0.22 | 2.12%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.66M |
| Avg Daily Volume (30 D): |
1.1M |
| Avg Daily Volume (90 D): |
1.07M |
| Trade Size |
| Avg Trade Size (Sh.): |
131 |
| Avg Trade Size (Sh.) (30 D): |
74 |
| Avg Trade Size (Sh.) (90 D): |
75 |
| Institutional Trades |
| Total Inst.Trades: |
1,115 |
| Avg Inst. Trade: |
$1.62M |
| Avg Inst. Trade (30 D): |
$1.77M |
| Avg Inst. Trade (90 D): |
$2M |
| Avg Inst. Trade Volume: |
.15M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.93M |
| Avg Closing Trade (30 D): |
$1.92M |
| Avg Closing Trade (90 D): |
$2.16M |
| Avg Closing Volume: |
165.51K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
|
$.1
|
$-.05
|
|
Diluted EPS
|
|
$.1
|
$-.05
|
|
Revenue
|
$
|
$ 68.13M
|
$ 52.51M
|
|
Gross Profit
|
$
|
$ 61.76M
|
$ 46.93M
|
|
Net Income / Loss
|
$
|
$ 9.67M
|
$ -4.92M
|
|
Operating Income / Loss
|
$
|
$ 8.88M
|
$ -3M
|
|
Cost of Revenue
|
$
|
$ 6.37M
|
$ 5.58M
|
|
Net Cash Flow
|
$
|
$ 7.03M
|
$ 5M
|
|
PE Ratio
|
|
|
|
|
|
|
